[go: up one dir, main page]

WO2001032874A3 - Nouveaux polypeptides et acides nucleiques les codant - Google Patents

Nouveaux polypeptides et acides nucleiques les codant Download PDF

Info

Publication number
WO2001032874A3
WO2001032874A3 PCT/US2000/030188 US0030188W WO0132874A3 WO 2001032874 A3 WO2001032874 A3 WO 2001032874A3 US 0030188 W US0030188 W US 0030188W WO 0132874 A3 WO0132874 A3 WO 0132874A3
Authority
WO
WIPO (PCT)
Prior art keywords
novx
polypeptides
nucleic acids
acids encoding
encoding same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/030188
Other languages
English (en)
Other versions
WO2001032874A2 (fr
Inventor
Sudhirdas K Prayaga
Raymond J Taupier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CuraGen Corp filed Critical CuraGen Corp
Priority to AU14536/01A priority Critical patent/AU1453601A/en
Publication of WO2001032874A2 publication Critical patent/WO2001032874A2/fr
Publication of WO2001032874A3 publication Critical patent/WO2001032874A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne de nouveaux polynucléotides NOVX isolés et des polypeptides codés par ces polynucléotides NOVX. Elle concerne également les anticorps qui se lient de manière immunospécifique à un polypeptide NOVX ou n'importe quel dérivé, variant, mutant ou fragment du polypeptide NOVX, de polynucléotide ou d'anticorps. L'invention concerne également des procédés dans lesquels les polypeptides, polynucléotides et anticorps NOVX s'utilisent pour la détection et le traitement d'une vaste gamme d'états pathologiques et ont également d'autres usages.
PCT/US2000/030188 1999-11-01 2000-11-01 Nouveaux polypeptides et acides nucleiques les codant Ceased WO2001032874A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU14536/01A AU1453601A (en) 1999-11-01 2000-11-01 Novel polypeptides and nucleic acids encoding same

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US16299299P 1999-11-01 1999-11-01
US60/162,992 1999-11-01
US16302199P 1999-11-02 1999-11-02
US60/163,021 1999-11-02
US16386199P 1999-11-05 1999-11-05
US60/163,861 1999-11-05
US70310100A 2000-10-31 2000-10-31
US09/703,101 2000-10-31

Publications (2)

Publication Number Publication Date
WO2001032874A2 WO2001032874A2 (fr) 2001-05-10
WO2001032874A3 true WO2001032874A3 (fr) 2002-03-07

Family

ID=27496530

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/030188 Ceased WO2001032874A2 (fr) 1999-11-01 2000-11-01 Nouveaux polypeptides et acides nucleiques les codant

Country Status (2)

Country Link
AU (1) AU1453601A (fr)
WO (1) WO2001032874A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1334179A2 (fr) 2000-11-14 2003-08-13 Bristol-Myers Squibb Company Polynucleotide codant pour une nouvelle serpine humaine (lsi-01) secretee a partir des cellules lymphoides
PL2399598T3 (pl) * 2010-06-28 2015-02-27 Univ Freiburg Blokada przekazywania sygnału CCL18 poprzez CCR6, jako opcja terapeutyczna w chorobach zwłóknieniowych i nowotworze
JP5864564B2 (ja) 2010-06-28 2016-02-17 ユニベルシテーツクリニクム フライブルグ 線維性疾患および癌における治療選択肢としてのｃｃｒ６を介するｃｃｌ１８シグナル伝達の遮断
US12203927B2 (en) 2019-09-06 2025-01-21 Ut-Battelle, Llc Methods for immunoregulation by modulating plasminogen-apple-nematode (PAN) domain-containing proteins

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474979A1 (fr) * 1990-08-20 1992-03-18 American Cyanamid Company Séquence du gène du facteur neurotrohpique liant l'héparine
EP0569703A2 (fr) * 1992-04-24 1993-11-18 American Cyanamid Company Méthode de traitement et prévention d'infections virales utilisant HBNF et protéine MK

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474979A1 (fr) * 1990-08-20 1992-03-18 American Cyanamid Company Séquence du gène du facteur neurotrohpique liant l'héparine
EP0569703A2 (fr) * 1992-04-24 1993-11-18 American Cyanamid Company Méthode de traitement et prévention d'infections virales utilisant HBNF et protéine MK

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARRELL R W ET AL: "SERPINS: MOBILE CONFORMATIONS IN A FAMILY OF PROTEINASE INHIBITORS", CURRENT OPINION IN STRUCTURAL BIOLOGY,GB,CURRENT BIOLOGY LTD., LONDON, vol. 2, no. 3, 1992, pages 438 - 446, XP000335353, ISSN: 0959-440X *
MOHAMADZADEH M ET AL: "DENDRITIC CELLS PRODUCE MACROPHAGE INFLAMMATORY PROTEIN-1 GAMMA, A NEW MEMBER OF THE CC CHEMOKINE FAMILY", JOURNAL OF IMMUNOLOGY,US,THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 156, no. 9, 1 May 1996 (1996-05-01), pages 3102 - 3106, XP000673480, ISSN: 0022-1767 *
ZHANG N ET AL: "Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors", CURRENT OPINION IN HEMATOLOGY,US,RAPID SCIENCE PUBLISHERS, PHILADELPHIA, PA, vol. 6, no. 1, January 1999 (1999-01-01), pages 44 - 50, XP002122375, ISSN: 1065-6251 *

Also Published As

Publication number Publication date
WO2001032874A2 (fr) 2001-05-10
AU1453601A (en) 2001-05-14

Similar Documents

Publication Publication Date Title
WO2001092523A3 (fr) Nouveaux polynucleotides humains et polypeptides codes par ceux-ci
WO2000058473A3 (fr) Acides nucleiques comprenant des phases de lecture ouverte codant des polypeptides; «orfx»
WO2001007595A3 (fr) Nouveau facteur de croissance des fibroblastes et acides nucleiques codant ce dernier
WO2001036645A3 (fr) Nouveaux polypeptides et acides nucleiques codant les memes
WO2001049729A8 (fr) Nouveaux polypeptides et acides nucleiques codant ceux-ci
WO2002066647A3 (fr) Recepteur de cytokine de type 2 et acides nucleiques codant ce recepteur
WO2000053742A3 (fr) Polynucleotides et proteines codees par ceux-ci
WO2001074856A3 (fr) Polypeptides de type wnt-7b et acides nucleiques codant pour ceux-ci
WO2001070978A3 (fr) Nouveaux polypeptides et acides nucleiques codant ces polypeptides
WO2001062928A3 (fr) Polypeptides et acides nucleiques codant pour
WO2002002625A3 (fr) Nouveaux facteurs de croissance des fibroblastes et acides nucleiques codant pour ces memes facteurs
WO2001061009A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2001036638A3 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces polypeptides
WO2001044473A3 (fr) Polypeptides et acides nucleiques codant pour ces polypeptides
WO2000061754A3 (fr) Nouvelles proteines humaines et polypeptides codant pour ces proteines
WO2003025147A3 (fr) Nouveaux polynucleotides et proteines codees par ceux-ci
WO2001068851A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2001032874A3 (fr) Nouveaux polypeptides et acides nucleiques les codant
WO2001023561A3 (fr) Nouveaux polynucleotides codant des proteines contenant des sequences repetees de thrombospondine type 1 (tsrx)
WO2000070046A3 (fr) Nouveaux polypeptides et polynucleotides les codant
WO2003040345A3 (fr) Recepteur de cytokine de type 2 et acides nucleiques codant ce dernier
WO2001023572A3 (fr) Nouveaux polynucleotides et polypeptides codes par ces derniers
WO2000075321A3 (fr) Nouveaux polynucleotides et polypeptides codant pour lesdits polynucleotides
WO2001004145A3 (fr) Famille de polypeptides glutx et acides nucleiques les codant
WO2001061008A3 (fr) Nouveaux polypeptides et acides nucleiques codant pour lesdits polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase